Part D In 2010: No Reference Pricing, More CMS Scrutiny Of Formulary Edits
Executive Summary
The last CMS 1draft "call letter" to Medicare Part D contractors to be issued under the current administration emphasizes familiar themes - concern with information transparency and ensuring appropriate access to drugs - and includes little in the way of drug coverage policy changes
You may also be interested in...
More Resources, Earlier Contact Would Improve Payer-Pharma Relationships
Biopharma companies could build stronger relationships with payers by adding resources and establishing earlier contacts with them, Cutting Edge Information concludes in a study on pharma's efforts to secure market access for products
More Resources, Earlier Contact Would Improve Payer-Pharma Relationships
Biopharma companies could build stronger relationships with payers by adding resources and establishing earlier contacts with them, Cutting Edge Information concludes in a study on pharma's efforts to secure market access for products
PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS
The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans